Delaware House Bill 16
Session 152
An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.
Became Law
Signed by Governor on Oct 9, 2024
Sponsors
21 Sponsors
First Action
Feb 29, 2024
Latest Action
Oct 9, 2024
Origin Chamber
House
Type
Bill
Bill Number
16
State
Delaware
Session
152
checkPassed on June 11, 2024
Motion Text
SM
House Roll Call Votes
Yes
Other
Other
Stephanie T. Bolden
Yes
Yes
Summary
This Act requires that Medicaid and State employee health plans cover: (1) ovarian cancer monitoring tests for women treated for ovarian cancer; and (2) annual screening tests for women at risk for ovarian cancer.
Bill Text
Sort by most recent
10/09/2024
Office of the Governor
Signed by Governor
06/30/2024
Senate
Passed By Senate. Votes: 21 YES
06/26/2024
Senate
Reported Out of Committee (Finance) in Senate with 4 On Its Merits
06/18/2024
Senate
Assigned to Finance Committee in Senate
06/18/2024
Senate
Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits
06/11/2024
Senate
Assigned to Health & Social Services Committee in Senate
06/11/2024
House
Passed By House. Votes: 39 YES 2 ABSENT
06/11/2024
House
Amendment HA 1 to HB 16 - Passed In House by Voice Vote
05/22/2024
House
Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits
05/21/2024
House
Amendment HA 1 to HB 16 - Introduced and Placed With Bill
03/19/2024
House
Assigned to Appropriations Committee in House
03/13/2024
House
Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits
02/29/2024
House
Introduced and Assigned to Health & Human Development Committee in House
Sources
Open States
Record Created
Mar 1, 2024 12:48:05 AM
Record Updated
Nov 7, 2024 4:30:52 PM